Progesterone Receptor Negative Active Not Recruiting Phase 1 Trials for Veliparib (DB07232)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00576654Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by SurgeryTreatment